Literature DB >> 1972565

Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction.

W M Nillesen1, H J Smeets, B A van Oost.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1972565      PMCID： PMC330980          DOI： 10.1093/nar/18.11.3428-a

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  2 in total

1.  A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia.

Authors:  E C Klasen; P J Talmud; L Havekes; E de Wit; E van der Kooij-Meijs; M Smit; G Hansson; S E Humphries
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

2.  Exact localization of the familial dysbetalipoproteinemia associated HpaI restriction site in the promoter region of the APOC1 gene.

Authors:  M Smit; E van der Kooij-Meijs; L P Woudt; L M Havekes; R R Frants
Journal:  Biochem Biophys Res Commun       Date:  1988-05-16       Impact factor: 3.575
  2 in total
  8 in total

1.  Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.

Authors:  Xavier Pillois; Thomas Gautier; Benjamin Bouillet; Jean-Paul Pais de Barros; Aline Jeannin; Bruno Vergès; Jacques Bonnet; Laurent Lagrost
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

2.  The apolipoprotein CI A allele as a risk factor for Alzheimer's disease.

Authors:  S E Poduslo; M Neal; K Herring; J Shelly
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

3.  Genetic influences on Alzheimer's disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil.

Authors:  Juliana Fagion Lucatelli; Alessandra Chielle Barros; Vanessa Kappel da Silva; Fernanda da Silva Machado; Pâmela Camini Constantin; Ana Amélia Cipriani Dias; Mara Helena Hutz; Fabiana Michelsen de Andrade
Journal:  Neurochem Res       Date:  2011-05-01       Impact factor: 3.996

4.  Apolipoproteins E and C1 and brain morphology in memory impaired elders.

Authors:  J M Serra-Grabulosa; P Salgado-Pineda; C Junqué; C Solé-Padullés; P Moral; A López-Alomar; T López; A López-Guillén; N Bargalló; J M Mercader; I C Clemente; D Bartrés-Faz
Journal:  Neurogenetics       Date:  2002-12-21       Impact factor: 2.660

5.  Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.

Authors:  P de Knijff; A M van den Maagdenberg; D I Boomsma; A F Stalenhoef; A H Smelt; J J Kastelein; A D Marais; R R Frants; L M Havekes
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  An improved RSP method to detect HpaI polymorphism in the apolipoprotein C-1 gene promoter.

Authors:  Li Gao; Curt Gabriel; Tera Lavoie; Shui Qing Ye
Journal:  BMC Med Genet       Date:  2002-11-12       Impact factor: 2.103

7.  Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.

Authors:  Raoudha Bahri; Esther Esteban; Pedro Moral; Mohsen Hassine; Khaldoun Ben Hamda; Hassen Chaabani
Journal:  Lipids Health Dis       Date:  2008-11-17       Impact factor: 3.876

8.  APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease.

Authors:  Qin Zhou; Dantao Peng; Xinrui Yuan; Zeping Lv; Shenghang Pang; Wenyu Jiang; Chuyu Yang; Xiaohong Shi; Guofang Pang; Yige Yang; Haiqun Xie; Wandong Zhang; Caiyou Hu; Ze Yang
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.